Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma of Lung

Explore clinical trials studying Adenocarcinoma of Lung. Study availability and eligibility vary by location and protocol.

266 public trials 48 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma of Lung trial results

Recruiting

A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea

NCT05703516

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Novartis Investigative Site Daegu, Dalseo gu, South Korea
  • Novartis Investigative Site Suwon, Gyeonggi-do, South Korea
  • Novartis Investigative Site Incheon, Korea, South Korea
  • Novartis Investigative Site Seoul, Korea, South Korea
View Trial Details
Recruiting

A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma

NCT05456256

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +12 more
Locations
  • Precision NextGen Oncology and Research Center Beverly Hills, California, United States
  • Los Angeles Cancer Network Fountain Valley, California, United States
  • Cancer and Blood Specialists Clinic Los Alamitos, California, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View all 16 locations
View Trial Details
Recruiting

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

NCT04937283

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
Locations
  • Anhui Chest Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • Nanyang Central Hospital Nanyang, Henan, China
  • The Sixth People's Hospital of Nantong Nantong, Jiangsu, China
View all 14 locations
View Trial Details
Recruiting

Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases

NCT07481786

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bevacizumab, +18 more
Locations
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Sun yat-sen University Cancer Center Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou, Guangdong, China
View Trial Details

Related conditions